SPPI Spectrum Pharmaceuticals, Inc. Stock Quote

SPPI [NASD]

Index	-	P/E	-	EPS (ttm)	-0.87	Insider Own	0.90%	Shs Outstand	169.74M	Perf Week	2.39%
Market Cap	154.89M	Forward P/E	-	EPS next Y	-0.13	Insider Trans	-16.40%	Shs Float	162.50M	Perf Month	20.49%
Income	-138.20M	PEG	-	EPS next Q	-0.16	Inst Own	40.90%	Short Float	7.85%	Perf Quarter	-32.56%
Sales	-	P/S	-	EPS this Y	25.70%	Inst Trans	-26.79%	Short Ratio	5.49	Perf Half Y	-39.30%
Book/sh	0.33	P/B	2.58	EPS next Y	69.80%	ROA	-103.60%	Target Price	5.60	Perf Year	-78.38%
Cash/sh	0.49	P/C	1.74	EPS next 5Y	-	ROE	-190.30%	52W Range	0.60 - 4.03	Perf YTD	-33.09%
Dividend	-	P/FCF	-	EPS past 5Y	-1.30%	ROI	-	52W High	-78.89%	Beta	1.98
Dividend %	-	Quick Ratio	2.40	Sales past 5Y	-	Gross Margin	-	52W Low	41.63%	ATR	0.07
Employees	163	Current Ratio	2.40	Sales Q/Q	-	Oper. Margin	-	RSI (14)	53.10	Volatility	8.93% 9.13%
Optionable	Yes	Debt/Eq	0.00	EPS Q/Q	63.00%	Profit Margin	-	Rel Volume	0.59	Prev Close	0.86
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 12 AMC	Payout	-	Avg Volume	2.32M	Price	0.85
Recom	2.00	SMA20	4.14%	SMA50	2.67%	SMA200	-34.19%	Volume	1,395,060	Change	-1.19%

Sep-17-20

Initiated

JMP Securities

Mkt Outperform

$12

Dec-26-19

Downgrade

Guggenheim

Buy → Neutral

Dec-26-19

Downgrade

Cantor Fitzgerald

Overweight → Neutral

$17 → $4

Nov-27-19

Resumed

B. Riley FBR

Buy

$18

Jul-11-19

Initiated

B. Riley FBR

Buy

$18

Mar-15-19

Resumed

Jefferies

Buy

$21

Nov-12-18

Reiterated

B. Riley FBR

Buy

$35 → $29

Dec-18-17

Initiated

B. Riley FBR, Inc.

Buy

$26

Oct-24-17

Initiated

Guggenheim

Buy

$32

Oct-19-17

Reiterated

H.C. Wainwright

Buy

$20 → $29

Oct-04-17

Reiterated

H.C. Wainwright

Buy

$14 → $20

Aug-16-17

Resumed

H.C. Wainwright

Buy

$14

Feb-10-17

Resumed

Jefferies

Buy

Nov-05-15

Reiterated

RBC Capital Mkts

Outperform

$13 → $12

Aug-07-15

Reiterated

RBC Capital Mkts

Outperform

$12 → $13

Apr-02-15

Initiated

FBR Capital

Outperform

Feb-23-15

Downgrade

ROTH Capital

Buy → Neutral

$15 → $7

Jul-15-14

Upgrade

R. F. Lafferty

Sell → Neutral

$7.50

Oct-07-13

Initiated

HC Wainwright

Buy

$15

May-29-13

Initiated

Burrill Institutional Research

Mkt Outperform

$12

Jun-13-22 01:53PM	We're A Little Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate Simply Wall St. -6.72%
Jun-02-22 07:00AM	Spectrum Pharmaceuticals to Participate in Two Upcoming Investor Conferences Business Wire +8.50%
May-26-22 05:01PM	Spectrum Pharmaceuticals to Present Data at 2022 ASCO Highlighting the Potential Predictive Capabilities of ctDNA as a Biomarker for Poziotinib Treatment Response Business Wire
May-17-22 07:00AM	Spectrum Pharmaceuticals to Participate in H.C. Wainwright Global Investment Conference Business Wire
May-14-22 09:18AM	Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI): Is Breakeven Near? Simply Wall St.
May-13-22 12:00AM	Spectrum Pharmaceuticals (SPPI) Q1 2022 Earnings Call Transcript Motley Fool
May-12-22 04:00PM	Spectrum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update Business Wire
May-11-22 07:00AM	Spectrum Pharmaceuticals Appoints Nora E. Brennan as Chief Financial Officer Business Wire -11.22%
May-06-22 07:00AM	Spectrum Pharmaceuticals to Report First Quarter 2022 Financial Results and Provide Corporate Update Business Wire
May-05-22 07:00AM	Spectrum Pharmaceuticals Appoints Brittany K. Bradrick to Board of Directors Business Wire
Apr-11-22 07:00AM	Spectrum Pharmaceuticals Announces FDA Acceptance of BLA Resubmission for Eflapegrastim Business Wire
Apr-04-22 07:00AM	Spectrum Pharmaceuticals Announces Poster Presentation at the Upcoming AACR Annual Meeting Business Wire +6.87%
Mar-18-22 02:05PM	HC Wainwright Sees Almost 1000% Upside On Spectrum Pharma Stock Benzinga +5.67%
Mar-17-22 04:00PM	Spectrum Pharmaceuticals Reports Fourth Quarter 2021 and Full Year 2021 Financial Results and Corporate Update Business Wire +10.35%
Mar-11-22 07:00AM	Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2021 Financial Results and Provide Corporate Update Business Wire
Mar-10-22 07:00AM	Spectrum Pharmaceuticals Appoints Juhyun Lim of Hanmi Pharmaceutical to Board of Directors Business Wire
Mar-07-22 07:54AM	Spectrum Pharma Highlights Poziotinib Data In Treatment-Naïve Lung Cancer Setting Benzinga +10.76%
06:00AM	Spectrum Pharmaceuticals Presents Positive Data for Poziotinib in First-line NSCLC Patients with HER2 Exon 20 Insertion Mutations Business Wire
Feb-28-22 07:00AM	Spectrum Pharmaceuticals Announces an Oral Poziotinib Presentation at the Upcoming ESMO TAT 2022 Virtual Meeting Business Wire
Feb-11-22 07:00AM	Spectrum Pharmaceuticals Announces Acceptance of New Drug Application Filing for Poziotinib Business Wire +6.35%
Feb-01-22 10:00AM	Down 55.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Spectrum Pharma (SPPI) Zacks +11.98%
Jan-26-22 06:44PM	Constellation Energy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 PR Newswire
Jan-20-22 07:00AM	Spectrum Pharmaceuticals to Participate in B. Riley Securities 2022 Virtual Oncology Conference Business Wire -5.61%
Jan-05-22 08:00AM	Spectrum Pharmaceuticals Announces Strategic Restructuring Business Wire -11.19%
Jan-04-22 07:00AM	Spectrum Pharmaceuticals Announces New Strategic Investment by Hanmi Pharmaceutical Business Wire -10.06%
Dec-22-21 11:00AM	SHAREHOLDER ALERT: Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Misleading Shareholders ACCESSWIRE
Dec-15-21 08:07AM	Did You Acquire (SPPI) Before December 27, 2018? Should Spectrum Pharmaceuticals Management be Held Accountable for Investors Losses? Contact Johnson Fistel GlobeNewswire +7.14%
Dec-10-21 08:35AM	Do Options Traders Know Something About Spectrum Pharmaceuticals (SPPI) Stock We Don't? Zacks -7.79%
Dec-06-21 10:00AM	Down 38% in 4 Weeks, Here's Why You Should You Buy the Dip in Spectrum Pharma (SPPI) Zacks
07:00AM	Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib Business Wire
Dec-01-21 04:00PM	Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors Business Wire +6.33%
Nov-30-21 07:00AM	Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summit Business Wire
Nov-11-21 07:00AM	Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference Business Wire
Nov-10-21 08:30PM	Spectrum Pharmaceuticals, inc (SPPI) Q3 2021 Earnings Call Transcript Motley Fool
04:00PM	Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Update Business Wire
Nov-03-21 07:00AM	Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Corporate Update Business Wire +7.77%
06:02AM	SHAREHOLDER ALERT: Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Misleading Shareholders Business Wire
Nov-01-21 04:14PM	SPPI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Spectrum Pharmaceuticals, Inc. Newsfile +5.46%
02:36PM	FINAL DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
02:11PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc of Class Action Lawsuit and Upcoming Deadline SPPI GlobeNewswire
01:47PM	SPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 1, 2021 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Limited Shareholders Newsfile
12:15PM	DEADLINE ALERT for SPPI and LDI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:30AM	CLASS ACTION UPDATE for SPPI, APPH and HYZN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:06AM	SPECTRUM DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Spectrum Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Business Wire
10:00AM	Final Hours to Participate in Spectrum Pharmaceuticals, Inc. (SPPI) Class Action - Bronstein, Gewirtz & Grossman, LLC Newsfile
09:13AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 1, 2021 - SPPI Newsfile
09:11AM	SPPI Final Deadline Today: Rosen, National Trial Lawyers, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important November 1 Deadline in Securities Class Action - SPPI Newsfile
07:45AM	DEADLINE TODAY: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-31-21 10:35AM	SHAREHOLDER ALERT: SPPI SAM WDH: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Oct-30-21 01:18PM	SPPI FINAL DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors With Losses to Secure Counsel Before Important Monday Deadline in Securities Class Action SPPI GlobeNewswire
Oct-29-21 03:53PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc of Class Action Lawsuit and Upcoming Deadline - SPPI Newsfile -5.67%
02:23PM	Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. (SPPI) GlobeNewswire
02:00PM	MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
01:45PM	FINAL DEADLINE: NOVEMBER 1, 2021 SPECTRUM PHARMACEUTICALS, INC. (NASDAQ: SPPI) CLASS ACTION LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. ACCESSWIRE
12:40PM	CLASS ACTION UPDATE for SPPI, INNV and ZEV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
11:00AM	Final Days to Participate in Spectrum Pharmaceuticals, Inc. (SPPI) Class Action - Bronstein, Gewirtz & Grossman, LLC Business Wire
09:00AM	LAWSUITS FILED AGAINST SPPI, WDH and RECAF - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
07:40AM	MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
Oct-28-21 05:45PM	SPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 1, 2021 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Limited Shareholders Newsfile +7.78%
04:15PM	IMPENDING DEADLINE: NOVEMBER 1, 2021 SPECTRUM PHARMACEUTICALS, INC. (SPPI) CLASS ACTION LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. Newsfile
03:06PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 1, 2021 - SPPI Newsfile
01:37PM	DEADLINE MONDAY NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
12:30PM	SPPI Lawsuit Filed: Jakubowitz Law Pursues Claims on Behalf of Spectrum Pharmaceuticals, Inc. Shareholders Newsfile
11:00AM	SPPI, LDI & LGVN Upcoming Class Actions - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
08:59AM	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 1, 2021 - (SPPI) Newsfile
07:30AM	DEADLINE MONDAY REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:19AM	SPPI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Spectrum Pharmaceuticals, Inc. Newsfile
Oct-27-21 10:55PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc of Class Action Lawsuit and Upcoming Deadline SPPI ACCESSWIRE
10:42PM	ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important November 1 Deadline in Securities Class Action - SPPI PR Newswire
09:00PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spectrum and loanDepot and Encourages Investors to Contact the Firm GlobeNewswire
05:38PM	SPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 1, 2021 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Limited Shareholders Newsfile
04:10PM	FINAL ALERT: Robbins Geller Rudman & Dowd LLP Announces that Spectrum Pharmaceuticals, Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - SPPI GlobeNewswire
02:49PM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 1, 2021 - SPPI Newsfile
01:18PM	DEADLINE MONDAY ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
12:31PM	DEADLINE ALERT for SPPI, LDI, SAM: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
09:00AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SPPI, SAM and HNST ACCESSWIRE
07:45AM	MONDAY DEADLINE NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:40AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SPPI, EAR and NNOX ACCESSWIRE
Oct-26-21 09:45PM	MONDAY DEADLINE: Spectrum Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Case - SPPI Newsfile
05:24PM	SPPI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Spectrum Pharmaceuticals, Inc. Newsfile
03:45PM	SHAREHOLDER FILING DEADLINE: NOVEMBER 1, 2021 SPECTRUM PHARMACEUTICALS, INC. (NASDAQ: SPPI) CLASS ACTION LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. GlobeNewswire
03:00PM	The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Spectrum Pharmaceuticals, Inc. (SPPI) Investors PR Newswire
02:00PM	LAWSUITS FILED AGAINST SPPI HNST and HEPS - Jakubowitz Law Pursues Shareholders Claims ACCESSWIRE
01:13PM	MONDAY DEADLINE REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
12:45PM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SPPI, SAM and ZEV ACCESSWIRE
12:15PM	DEADLINE ALERT for SPPI and LDI: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders GlobeNewswire
11:29AM	SPPI ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 1, 2021 in the Class Action Filed on Behalf of Spectrum Pharmaceuticals, Inc. Limited Shareholders Newsfile
10:00AM	SPPI, LDI & LGVN Upcoming Class Action Deadlines - Bronstein, Gewirtz & Grossman, LLC GlobeNewswire
09:08AM	SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Spectrum Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 1, 2021 - SPPI Newsfile
07:40AM	MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
05:40AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HYRE, SPPI and NNOX ACCESSWIRE
Oct-25-21 11:38PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Spectrum Pharmaceuticals, Inc of Class Action Lawsuit and Upcoming Deadline - SPPI PR Newswire
03:55PM	CLASS ACTION UPDATE for SPPI, SAM and HEPS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
03:30PM	INVESTOR FILING DEADLINE: NOVEMBER 1, 2021 SPECTRUM PHARMACEUTICALS, INC. (NASDAQ: SPPI) CLASS ACTION LAWSUIT DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. ACCESSWIRE
02:50PM	FINAL DEADLINE APPROACHING: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:45AM	The Gross Law Firm Announces Class Actions on Behalf of Shareholders of SPPI, SAM and APPH ACCESSWIRE
11:00AM	SPPI, LDI & LGVN Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Actions and Upcoming Deadlines ACCESSWIRE
09:00AM	The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of HYRE, SPPI and WDH ACCESSWIRE
08:07AM	7-DAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Spectrum Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Newsfile
Oct-24-21 10:20AM	CLASS ACTION UPDATE for KPLT, SPPI and ZEV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Henderson, Nevada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LEBEL FRANCOIS	Chief Medical Officer	Jun 23	Sale	0.84	6,667	5,594	644,790	Jun 23 08:24 PM
LEBEL FRANCOIS	Chief Medical Officer	Jun 22	Sale	0.81	6,096	4,913	651,457	Jun 23 08:24 PM
Brennan Nora	EVP & CFO	Jun 21	Sale	0.79	3,569	2,802	360,215	Jun 23 07:56 PM
Vyas Dolatrai	Former Director	Jun 21	Sale	0.79	4,283	3,362	82,063	Jun 22 09:45 PM
Ashton William	Director	Jun 21	Sale	0.79	4,283	3,362	42,660	Jun 22 09:20 PM
Fischer Seth H. Z.	Director	Jun 21	Sale	0.79	5,711	4,483	29,066	Jun 22 09:55 PM
LEBEL FRANCOIS	Chief Medical Officer	Apr 05	Sale	1.41	1,367	1,927	252,513	Apr 05 05:42 PM
LEBEL FRANCOIS	Chief Medical Officer	Apr 04	Sale	1.35	1,205	1,627	253,880	Apr 05 05:42 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Mar 16	Sale	0.71	16,318	11,521	317,259	Mar 16 06:15 PM
Riga Thomas J	CEO & President	Mar 16	Sale	0.71	18,829	13,293	568,800	Mar 16 06:29 PM
McGahan Keith M	Chief Legal Officer	Mar 16	Sale	0.71	16,318	11,521	244,940	Mar 16 06:39 PM
LEBEL FRANCOIS	Chief Medical Officer	Mar 16	Sale	0.71	25,105	17,724	255,085	Mar 16 07:11 PM
LEBEL FRANCOIS	Chief Medical Officer	Mar 15	Sale	0.70	25,130	17,717	280,190	Mar 16 07:11 PM
McGahan Keith M	Chief Legal Officer	Mar 15	Sale	0.70	14,658	10,334	261,258	Mar 16 06:39 PM
Riga Thomas J	CEO & President	Mar 15	Sale	0.70	20,356	14,351	587,629	Mar 16 06:29 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Mar 15	Sale	0.70	20,653	14,560	333,577	Mar 16 06:15 PM
McGahan Keith M	Chief Legal Officer	Feb 24	Sale	0.64	15,031	9,620	275,916	Feb 24 07:21 PM
Riga Thomas J	CEO & President	Feb 24	Sale	0.64	18,441	11,802	607,985	Feb 24 08:42 PM
LEBEL FRANCOIS	Chief Medical Officer	Feb 24	Sale	0.64	14,708	9,413	305,320	Feb 24 09:04 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Feb 24	Sale	0.64	15,958	10,213	354,230	Feb 24 06:43 PM
GUSTAFSON KURT A	EVP & Chief Financial Officer	Feb 23	Sale	0.70	20,215	14,211	366,188	Feb 24 06:43 PM
LEBEL FRANCOIS	Chief Medical Officer	Feb 23	Sale	0.70	13,466	9,467	320,028	Feb 24 09:04 PM
Riga Thomas J	CEO & President	Feb 23	Sale	0.70	19,953	14,027	626,426	Feb 24 08:42 PM
McGahan Keith M	Chief Legal Officer	Feb 23	Sale	0.70	13,513	9,500	290,947	Feb 24 07:21 PM
LEBEL FRANCOIS	Chief Medical Officer	Nov 09	Sale	2.18	6,000	13,080	329,166	Nov 10 08:32 PM
LEBEL FRANCOIS	Chief Medical Officer	Nov 08	Sale	2.20	7,363	16,221	335,166	Nov 10 08:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience